ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael R.C. Gough
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tien, H. C.N.
Right arrow Articles by Macdonald, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tien, H. C.N.
Right arrow Articles by Macdonald, J.
Related Collections
Right arrow Chest wall
Right arrow Lung - other

Ann Thorac Surg 2007;84:1373-1374
© 2007 The Society of Thoracic Surgeons

Case Reports

Successful Use of Recombinant Activated Coagulation Factor VII in a Patient with Massive Hemoptysis From a Penetrating Thoracic Injury

Homer C.N. Tien, MD, MSca,b,*, Michael R.C. Goughc,d, Robert Farrell, MD, MSce, John Macdonald, MD, MScb,f

a The Trauma Program and the Department of Surgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
b Canadian Forces Health Services, Ottawa, Ontario, Canada
c St. George’s Hospital, University of London, London, United Kingdom
d Royal Army Medical Corps, British Army, London, United Kingdom
e Carbonear General Hospital, Newfoundland, Ottawa, Ontario, Canada
f Department of Critical Care Medicine, University of Ottawa, Ottawa, Ontario, Canada

Accepted for publication May 11, 2007.

* Address correspondence to Dr Tien, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Suite H186, Toronto, Ontario, M4N 3M5, Canada (Email: homer.tien{at}sunnybrook.ca).

Acute massive hemoptysis is a rare complication of pulmonary injury and contusion, and it is particularly difficult to manage in the nontertiary care setting. Recombinant activated coagulation factor VII (rFVIIa) is a prothrombotic drug that is increasingly being used to treat coagulopathy in massively exsanguinating trauma patients. We report a case in which recombinant activated coagulation factor VII successfully controlled massive hemoptysis and improved ventilation from a severe pulmonary contusion in a noncoagulopathic patient who suffered a penetrating thoracic injury in a military setting in Afghanistan.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.